Zheng Xing Xing Ye Ri Bao·2025-08-26 08:35Market Overview - The Chinese medicine sector experienced a decline of 0.39% on August 26, with Enwei Pharmaceutical leading the drop [1] - The Shanghai Composite Index closed at 3868.38, down 0.39%, while the Shenzhen Component Index closed at 12473.17, up 0.26% [1] Stock Performance - Notable gainers in the Chinese medicine sector included: - ST Xiangxue: Closed at 11.74, up 12.45% with a trading volume of 532,400 shares and a turnover of 597 million yuan [1] - Wanbangde: Closed at 8.71, up 9.97% with a trading volume of 474,900 shares and a turnover of 397 million yuan [1] - Tailong Pharmaceutical: Closed at 7.24, up 5.39% with a trading volume of 541,000 shares and a turnover of 385 million yuan [1] - Conversely, Enwei Pharmaceutical saw a decline of 4.76%, closing at 37.22 with a trading volume of 32,400 shares and a turnover of 123 million yuan [2] Capital Flow - The Chinese medicine sector saw a net outflow of 1.019 billion yuan from institutional investors, while retail investors contributed a net inflow of 764 million yuan [2] - Specific stock capital flows included: - Wanbangde: Net inflow from institutional investors of 11.5 million yuan, but net outflows from retail investors [3] - Yiling Pharmaceutical: Net inflow from institutional investors of 71.17 million yuan [3] - Tianshili: Net inflow from institutional investors of 48.64 million yuan [3]